Target intelligence / Profile preview

Novel transcript, sense intronic to ERC2 (ENSG00000306397)

Target: ENSG00000306397
Molecular classification: non-coding RNA transcript

Overview

This entity is an RNA transcript annotated as “novel transcript, sense intronic to ERC2,” detected within the intronic region of the ERC2 gene on human chromosome 3[1]. It does not encode a known protein and is not recognized as a canonical therapeutic target such as a receptor, enzyme, ion channel, transporter, or transcription factor. There are no established biological functions, disease associations, or clinical applications. Its detection in databases likely reflects high-throughput transcriptomics annotation rather than confirmed biological or pharmacological relevance[1].

Other names: ERC2 intronic sense transcript

Beyond the preview

Go deeper on Novel transcript, sense intronic to ERC2 (ENSG00000306397).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to ERC2 (ENSG00000306397).

Explore the full profile